Lantern Pharma Raises $3.7 M in Series A Financing

PRESS RELEASE:Financing to Support Development of Precision Oncology Treatments Driven by Advanced Genomics, Big Data and Artificial IntelligenceDALLAS–(BUSINESS WIRE)–May 2, 2017– Today Lantern Pharma Inc. announced the closure of its Series A equity financing of $3.7 million for the biotech company and its clinical-stage cancer treatments. This Series A closing was led by Bios Partners, GPG Ventures and other private investors. Lantern Pharma Inc. is a clinical-stage biotech